))
Ep. 58 - Ysios' Karen Wagner: How Europe's Biotechs Can Rise Above the Noise
Manage episode 416067019 series 3571902
BioCentury에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 BioCentury 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
It sounds obvious, but still needs saying, says Ysios Capital's Karen Wagner. “How do you rise above the noise? By having the most spectacular data.” In conversation with Editor in Chief Simone Fishburn on The BioCentury Show, Wagner discussed the theme of the upcoming Bio€quity Europe conference — rising above the noise: in a sea of competition where companies vie for attention among investors and pharmas, what are the characteristics that allow them to differentiate? Wagner explains what she and her team looks for in a biotech before investing, and also discusses the role of ESG policies, including diversity, in companies. “We have absolute certainty that ESG is important."
View full story: https://www.biocentury.com/article/652294
#biotech #biopharma #pharma #lifescience #finance
00:00 - Intro
01:36 - Spain’s Biotech Ecosystem
09:30 - Investment Criteria
14:27 - ESG, Diversity
27:53 - AI in Drug Development
챕터
1. Ep. 58 - Ysios' Karen Wagner: How Europe's Biotechs Can Rise Above the Noise (00:00:00)
2. Spain’s Biotech Ecosystem (00:01:36)
3. Investment Criteria (00:09:30)
4. ESG, Diversity (00:14:27)
5. AI in Drug Development (00:27:53)
22 에피소드
공유
